Snoring, often dismissed as a mere nuisance, can serve as a warning sign for a serious condition known as obstructive sleep apnea syndrome (OSAS). Studies reveal that approximately 50 percent of individuals who snore may suffer from sleep apnea, a disorder associated with potentially life-threatening complications such as heart disease, hypertension, stroke, and even sudden death in severe cases.

In response to the urgent need for efficient detection and monitoring of sleep apnea, the Sleep Medicine Center at China Medical University Hospital (CMUH) in Taiwan has introduced a solution named iDREAM (Intelligent Detection of Respiratory Events through Automated Monitoring). This innovative system incorporates Quanta's QOCA Portable ECG Monitoring Device to enable simple and effective detection of apnea symptoms during sleep at home.

More than 100 patients have participated in clinical trials of iDREAM, which employs AI-powered ECG analysis to accurately identify obstructive sleep apnea syndrome (OSAS) and streamline the diagnosis and treatment process. Dr. Yung-An Tsou, Director of the Laryngology Division at CMUH, emphasized the significance of this technology, citing a survey by the Asian Society of Sleep Medicine indicating that over 20 percent of Taiwan's population, approximately 5 million people, suffer from sleep disorders, with a substantial gap between the number of affected individuals and those seeking medical treatment.

One such beneficiary of iDREAM is Chang, 36, who struggled with disruptive snoring and poor sleep quality. Following preliminary examinations by CMUH's expert team, Chang underwent a sleep exam, revealing a diagnosis of OSAS. Subsequent treatment with uvulopalatopharyngoplasty (UPPP) and monitoring with iDREAM resulted in significant improvement in Chang's sleep quality and alleviation of his sleep apnea symptoms.

Dr. Liang-Wen Hang, Chief of CMUH Sleep Medicine Center, highlighted the challenges faced by traditional sleep monitoring methods, including limited capacity, patient discomfort due to multiple sensors, and manpower constraints. iDREAM addresses these issues by providing continuous home monitoring, reducing scheduling conflicts, and enhancing patient comfort and convenience.

iDREAM utilizes deep learning methodology to detect ECG changes indicative of OSAS episodes with impressive accuracy, demonstrating potential for widespread impact in sleep medicine. Plans are underway to obtain certification from the Taiwan Food and Drug Administration for formal introduction into clinical practice.

Furthermore, CMUH's AI Center plays a key role in advancing intelligent healthcare solutions, leveraging clinical data to train artificial neural networks and develop decision-making systems aimed at easing the burden on healthcare personnel. With numerous certifications already obtained from the Taiwan Food and Drug Administration, CMUH's AI Center continues to innovate, promising further breakthroughs in the sector of smart healthcare.